For the predominant functional modules, the top interacting DEGs to anti-TNF drug between non-responders and responders were mainly enriched in immune-related functions, including the ‘IL-17 signaling’, ‘Rheumatoid arthritis’, and ‘Cytokine-cytokine receptor interaction’ pathways (Figure 3). This evidence concerns the gene IL17A and rheumatoid arthritis.